Zheng Kang, Cubero Francisco Javier, Nevzorova Yulia A
Department of Immunology, Complutense University School of Medicine, Plaza Ramón y Cajal s/n, Madrid 28040, Spain.
12 de Octubre Health Research Institute (imas12), Madrid 28041, Spain.
Genes (Basel). 2017 Apr 19;8(4):123. doi: 10.3390/genes8040123.
Over 35 years ago, c-MYC, a highly pleiotropic transcription factor that regulates hepatic cell function, was identified. In recent years, a considerable increment in the number of publications has significantly shifted the way that the c-MYC function is perceived. Overexpression of c-MYC alters a wide range of roles including cell proliferation, growth, metabolism, DNA replication, cell cycle progression, cell adhesion and differentiation. The purpose of this review is to broaden the understanding of the general functions of c-MYC, to focus on c-MYC-driven pathogenesis in the liver, explain its mode of action under basal conditions and during disease, and discuss efforts to target c-MYC as a plausible therapy for liver disease.
35多年前,c-MYC被发现,它是一种调节肝细胞功能的高度多效性转录因子。近年来,出版物数量的显著增加极大地改变了人们对c-MYC功能的认知方式。c-MYC的过表达改变了包括细胞增殖、生长、代谢、DNA复制、细胞周期进程、细胞黏附和分化在内的广泛作用。本综述的目的是拓宽对c-MYC一般功能的理解,聚焦于c-MYC驱动的肝脏发病机制,解释其在基础条件和疾病期间的作用模式,并讨论将c-MYC作为肝病合理治疗靶点的相关研究进展。